Treatment of anticoagulated patients with negative pressure wound therapy

© 2017 John Wiley & Sons Ltd and Medicalhelplines.com Inc.There is a paucity of evidence surrounding the use of negative pressure wound therapy (NPWT) in patients receiving anticoagulant medication. Guidelines generally recommend caution regarding the use of NPWT in anticoagulated patients in ge...

Full description

Bibliographic Details
Main Authors: Boxall, S., Carville, K., Leslie, Gavin, Jansen, S.
Format: Journal Article
Published: Wiley-Blackwell Publishing Ltd 2017
Online Access:http://hdl.handle.net/20.500.11937/51739
_version_ 1848758763220107264
author Boxall, S.
Carville, K.
Leslie, Gavin
Jansen, S.
author_facet Boxall, S.
Carville, K.
Leslie, Gavin
Jansen, S.
author_sort Boxall, S.
building Curtin Institutional Repository
collection Online Access
description © 2017 John Wiley & Sons Ltd and Medicalhelplines.com Inc.There is a paucity of evidence surrounding the use of negative pressure wound therapy (NPWT) in patients receiving anticoagulant medication. Guidelines generally recommend caution regarding the use of NPWT in anticoagulated patients in general, but areas of particular risk are frequently not highlighted. The US Food and Drug Authority (FDA) reported six mortalities between 2009 and 2011 in patients receiving NPWT. These mortalities were associated with the use of NPWT over vascular graft sites. The coagulation status of these patients was not reported. It is the authors' recommendation that guidelines regarding the use of NPWT in anticoagulated patients highlight specific clinical situations of risk, although there is insufficient evidence to support the avoidance of NPWT in anticoagulated patients in general.
first_indexed 2025-11-14T09:49:09Z
format Journal Article
id curtin-20.500.11937-51739
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:49:09Z
publishDate 2017
publisher Wiley-Blackwell Publishing Ltd
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-517392017-09-13T15:37:23Z Treatment of anticoagulated patients with negative pressure wound therapy Boxall, S. Carville, K. Leslie, Gavin Jansen, S. © 2017 John Wiley & Sons Ltd and Medicalhelplines.com Inc.There is a paucity of evidence surrounding the use of negative pressure wound therapy (NPWT) in patients receiving anticoagulant medication. Guidelines generally recommend caution regarding the use of NPWT in anticoagulated patients in general, but areas of particular risk are frequently not highlighted. The US Food and Drug Authority (FDA) reported six mortalities between 2009 and 2011 in patients receiving NPWT. These mortalities were associated with the use of NPWT over vascular graft sites. The coagulation status of these patients was not reported. It is the authors' recommendation that guidelines regarding the use of NPWT in anticoagulated patients highlight specific clinical situations of risk, although there is insufficient evidence to support the avoidance of NPWT in anticoagulated patients in general. 2017 Journal Article http://hdl.handle.net/20.500.11937/51739 10.1111/iwj.12737 Wiley-Blackwell Publishing Ltd restricted
spellingShingle Boxall, S.
Carville, K.
Leslie, Gavin
Jansen, S.
Treatment of anticoagulated patients with negative pressure wound therapy
title Treatment of anticoagulated patients with negative pressure wound therapy
title_full Treatment of anticoagulated patients with negative pressure wound therapy
title_fullStr Treatment of anticoagulated patients with negative pressure wound therapy
title_full_unstemmed Treatment of anticoagulated patients with negative pressure wound therapy
title_short Treatment of anticoagulated patients with negative pressure wound therapy
title_sort treatment of anticoagulated patients with negative pressure wound therapy
url http://hdl.handle.net/20.500.11937/51739